AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 26-50/58
THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/
Authors: HERNBERG M MUHONEN T TURUNEN JP HAHKAKEMPPINEN M PYRHONEN S
Citation: M. Hernberg et al., THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/, Journal of clinical oncology, 14(5), 1996, pp. 1690-1696
THE EFFECT OF ANTIESTROGENS ON CYTOKINE PRODUCTION IN-VITRO
Authors: JARVINEN LS PYRHONEN S KAIREMO KJA PAAVONEN T
Citation: Ls. Jarvinen et al., THE EFFECT OF ANTIESTROGENS ON CYTOKINE PRODUCTION IN-VITRO, Scandinavian journal of immunology, 44(1), 1996, pp. 15-20
RADIOSENSITIVITY OF MESOTHELIOMA CELL-LINES
Authors: HAKKINEN AM LAASONEN A LINNAINMAA K MATTSON K PYRHONEN S
Citation: Am. Hakkinen et al., RADIOSENSITIVITY OF MESOTHELIOMA CELL-LINES, Acta oncologica, 35(4), 1996, pp. 451-456
A COMBINATION OF VINBLASTINE AND DOXORUBICIN WITH INTERFERON-ALPHA
Authors: JEKUNEN A PYRHONEN S
Citation: A. Jekunen et S. Pyrhonen, A COMBINATION OF VINBLASTINE AND DOXORUBICIN WITH INTERFERON-ALPHA, American journal of clinical oncology, 19(4), 1996, pp. 384-385
PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY
Authors: MUHONEN T JANTUNEN I PERTOVAARA H VOUTILAINEN L MAICHE A BLOMQVIST C PYRHONEN S KELLOKUMPULEHTINEN P
Citation: T. Muhonen et al., PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY, American journal of clinical oncology, 19(3), 1996, pp. 232-234
RADIATION-THERAPY OF INTRACRANIAL MALIGNANT-MELANOMA
Authors: ISOKANGAS OP MUHONEN T KAJANTI M PYRHONEN S
Citation: Op. Isokangas et al., RADIATION-THERAPY OF INTRACRANIAL MALIGNANT-MELANOMA, Radiotherapy and oncology, 38(2), 1996, pp. 139-144
EFFECT OF ANTIESTROGEN REGIMEN ON PROSTACYCLIN AND THROMBOXANE A(2) IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER - EVIDENCE OF SIGNIFICANCE OF HYPERTENSION, SMOKING OR PREVIOUS USE OF ESTROGEN THERAPY
Authors: MARTTUNEN MB PYRHONEN S TIITINEN AE VIINIKKA LU YLIKORKALA O
Citation: Mb. Marttunen et al., EFFECT OF ANTIESTROGEN REGIMEN ON PROSTACYCLIN AND THROMBOXANE A(2) IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER - EVIDENCE OF SIGNIFICANCE OF HYPERTENSION, SMOKING OR PREVIOUS USE OF ESTROGEN THERAPY, Prostaglandins, 52(4), 1996, pp. 317-326
EFFECT OF IV-INFUSION ON SALIVARY FLOW IN LYMPHOMA PATIENTS
Authors: MEURMAN JH LAINE P LINDQVIST C PYRHONEN S
Citation: Jh. Meurman et al., EFFECT OF IV-INFUSION ON SALIVARY FLOW IN LYMPHOMA PATIENTS, Journal of dental research, 75(5), 1996, pp. 1297-1297
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
Authors: ALBERTI W ANDERSON G BARTOLUCCI A BELL D VILLALBA JB BRODIN O CARDIELLO C CARTEI F CARTEI G CELLERINO R CHASTANG C CORMIER Y COX JD CRINO L CROWLEY J DAUTZENBERG B DEPIERRE A DIETEMANN A DILLMAN RO DOI O FELD R FIGLIN R GANZ PA GREEN MR GREGOR A HELLE PA HERNDON JE HITOMI S HOST H IMAIZUMI M JETT JR JOHNSON D KAASA S KIMURA H KLASTERSKY J KONDO H KREISMAN H KRIS MG KUNISHIMA K KUWAHARA O LAD TE LAING AH MACBETH F MASAOKA A MATTSON K MINATEL E MIRA JG MORI T MOUNTAIN CF NIEDERLE N NIIRANEN A NOU E PAGE W PATER J PIANTADOSI S PISTERS KMW PYRHONEN S QUOIX E RAPP E ROWELL NP SAHMOUD T SAWAMURA K SCHALLIER DCC SCOTT C SIMPSON J STAGG M TERAMATSU T TROVO MG TSUCHIYA R TUMMARELLO D VANHOUTTE P VANZANDWIJK N VINCENT RG WADA H WHITE JE WILLIAMS CJ WOODS RL YAMAGUCHI Y ARRIAGADA R CARTMELLDAVIES J GIRLING DJ LECHEVALIER T MARSONI S PARMAR MKB PIGNON JP REKACEWICZ C SOUHAMI RL STEWART LA TARAYRE M TINAZZI A TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
TAMOXIFEN AND TOREMIFENE - THE BENEFICIAL HYPOLIPEMIC EFFECT IN WOMENIS MEDIATED BY CHOLESTEROL-BIOSYNTHESIS INHIBITION
Authors: MANTYLA E GYLLING H KANGAS L PYRHONEN S MAENPAA H VALAVAARA R MIETTINEN T
Citation: E. Mantyla et al., TAMOXIFEN AND TOREMIFENE - THE BENEFICIAL HYPOLIPEMIC EFFECT IN WOMENIS MEDIATED BY CHOLESTEROL-BIOSYNTHESIS INHIBITION, European journal of cancer, 31A, 1995, pp. 60-60
INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA
Authors: KESOMAA M JEKUNEN A VLAYKOVA T WASENIUS VM KAIREMO KJA PYRHONEN S
Citation: M. Kesomaa et al., INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA, European journal of cancer, 31A, 1995, pp. 223-223
PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER
Authors: DALLEY D LEVI J BELL D GREEN M SHERMAN P ZALCBERG J ZIMET A THOMSON D WALPOLE E ACKLAND S STEWART J SCHULLER J FOGL U WIRTH M LUTZ D SALOMON J VANTRAPPEN G VANCUTSEM E LEPOUTRE L DEFACQ L BURY J REGINSTER M FROIMTCHUK M DEOLIVEIRA MDLL SCALETZKY A KOCHA W SKILLINGS J WEINERMAN B SHORE T MAROUN J CRIPPS C GOEL R BATIST G BOOS G GADEBERG C KJAER M BRUNSGAARD N JAKOBSEN A MEJLHOLM J BERTELSEN K MADSEN EL JORGENSEN A SANDBERG E PYRHONEN S ISOKANGAS OP JOHANSSON R KATAJA V ROUGIER P BECOUARN Y BRUNET R FRANCOIS E NAMER M SEITZ J GIOVANNINI H REBATTU P MERROUCHE Y LANKISCH P HEISE J MAY B GREVING J SODOMANN C BERGERMANN H MERTELSMANN R SCHUPP M PORZSOLT F STEINACKER RM CARTEI G BAJETTA E COLLEONI M PANNUTI E FOSSER V BERG C RAVN H EGELI R GUILLOU P SOMERS S CAREY P PRIMROSE J SELBY P WARD U BUDDE M HOLDENER EE MAN A MASSIMINI G SMITH H LUYKX R BLAES C YAP AKL HOLMSTROM S COCKEY L
Citation: D. Dalley et al., PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 921-928
TAMOXIFEN AND TOREMIFENE LOWER SERUM-CHOLESTEROL BY INHIBITION OF DELTA(8)-CHOLESTENOL CONVERSION TO LATHOSTEROL IN WOMEN WITH BREAST-CANCER
Authors: GYLLING H PYRHONEN S MANTYLA E MAENPAA H KANGAS L MIETTINEN TA
Citation: H. Gylling et al., TAMOXIFEN AND TOREMIFENE LOWER SERUM-CHOLESTEROL BY INHIBITION OF DELTA(8)-CHOLESTENOL CONVERSION TO LATHOSTEROL IN WOMEN WITH BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2900-2905
RISK OF 2ND CANCERS AMONG LUNG-CANCER PATIENTS
Authors: SALMINEN E PUKKALA E TEPPO L PYRHONEN S
Citation: E. Salminen et al., RISK OF 2ND CANCERS AMONG LUNG-CANCER PATIENTS, Acta oncologica, 34(2), 1995, pp. 165-169
RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY
Authors: HAHKAKEMPPINEN M MUHONEN T VIROLAINEN M JEKUNEN A ASKOSELJAVAARA S PYRHONEN S
Citation: M. Hahkakemppinen et al., RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY, British journal of dermatology, 132(6), 1995, pp. 973-977
RANDOMIZED COMPARISON OF FLUOROURACIL, EPIDOXORUBICIN AND METHOTREXATE (FEMTX) PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH NONRESECTABLE GASTRIC-CANCER
Authors: PYRHONEN S KUITUNEN T NYANDOTO P KOURI M
Citation: S. Pyrhonen et al., RANDOMIZED COMPARISON OF FLUOROURACIL, EPIDOXORUBICIN AND METHOTREXATE (FEMTX) PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH NONRESECTABLE GASTRIC-CANCER, British Journal of Cancer, 71(3), 1995, pp. 587-591
DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/
Authors: MUHONEN T HAHKAKEMPPINEN M PAKKALA S PYRHONEN S
Citation: T. Muhonen et al., DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 67-73
EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW
Authors: MEURMAN JH LAINE P LINDQVIST C PYRHONEN S TEERENHOVI L
Citation: Jh. Meurman et al., EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW, European journal of cancer. Part B, Oral oncology, 30B(3), 1994, pp. 204-208
A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA
Authors: VUORISTO M JANTUNEN I PYRHONEN S MUHONEN T KELLOKUMPULEHTINEN P
Citation: M. Vuoristo et al., A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA, European journal of cancer, 30A(4), 1994, pp. 530-532
SUBSEQUENT PRIMARY CANCERS FOLLOWING BLADDER-CANCER
Authors: SALMINEN E PUKKALA E TEPPO L PYRHONEN S
Citation: E. Salminen et al., SUBSEQUENT PRIMARY CANCERS FOLLOWING BLADDER-CANCER, European journal of cancer, 30A(3), 1994, pp. 303-307
PHASE-II STUDY OF VINBLASTINE AND DOXORUBICIN IN ADVANCED RENAL-CELL CARCINOMA
Authors: JEKUNEN A STENGARD J PYRHONEN S
Citation: A. Jekunen et al., PHASE-II STUDY OF VINBLASTINE AND DOXORUBICIN IN ADVANCED RENAL-CELL CARCINOMA, European journal of cancer, 30A(2), 1994, pp. 245-245
SALVAGE THERAPIES IN WOMEN WHO FAIL TO RESPOND TO FIRST-LINE TREATMENT WITH FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER
Authors: PORKKA K BLOMQVIST C RISSANEN P ELOMAA I PYRHONEN S
Citation: K. Porkka et al., SALVAGE THERAPIES IN WOMEN WHO FAIL TO RESPOND TO FIRST-LINE TREATMENT WITH FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER, Journal of clinical oncology, 12(8), 1994, pp. 1639-1647
MOUSE SUBRENAL CAPSULE ASSAY CHEMOSENSITIVITY AND DNA FLOW-CYTOMETRY PARAMETERS OF HUMAN-MELANOMA METASTASES
Authors: MUHONEN T PYRHONEN S LAASONEN A WASENIUS VM ASKOSELJAVAARA S FRANSSILA K KANGAS L
Citation: T. Muhonen et al., MOUSE SUBRENAL CAPSULE ASSAY CHEMOSENSITIVITY AND DNA FLOW-CYTOMETRY PARAMETERS OF HUMAN-MELANOMA METASTASES, Acta oncologica, 33(4), 1994, pp. 431-437
EPIRUBICIN-SEQUENTIAL METHOTREXATE-5-FLUOROURACIL-LEUCOVORIN TREATMENT IN ADVANCED CANCER OF THE EXTRAHEPATIC BILIARY SYSTEM - A PHASE-II STUDY
Authors: KAJANTI M PYRHONEN S
Citation: M. Kajanti et S. Pyrhonen, EPIRUBICIN-SEQUENTIAL METHOTREXATE-5-FLUOROURACIL-LEUCOVORIN TREATMENT IN ADVANCED CANCER OF THE EXTRAHEPATIC BILIARY SYSTEM - A PHASE-II STUDY, American journal of clinical oncology, 17(3), 1994, pp. 223-226
HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT
Authors: PYRHONEN S VALAVAARA R VUORINEN J HAJBA A
Citation: S. Pyrhonen et al., HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT, Breast cancer research and treatment, 29(3), 1994, pp. 223-228
Risultati: 1-25 | 26-50 | 51-58